| Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease (NCT07619547) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Discovering Determinants of Food Intake by Application of Artificial Intelligence to Complex, High-Dimensional Data (NCT07637656) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity (NCT05713799) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Effects of Meal Macronutrients on Postprandial Lipids (NCT07313787) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Hepatic Lipid Metabolism-Alcohol Use Disorder (NCT07191561) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults (NCT07388537) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer (NCT06991738) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant (NCT05722210) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism (NCT06690294) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-26 |
| Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo (NCT07683026) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-08 |
| Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG (NCT07216391) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-07-30 |
| Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion (NCT07649317) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-07-27 |
| Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus (NCT07142252) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-05-14 |
| Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors (NCT07444723) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-04-16 |
| Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study (NCT06730113) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2025-03-12 |
| VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B (NCT06092333) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2025-01-31 |
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome (NCT06635629) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-12-12 |
| Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation (NCT06169137) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-09-04 |
| Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change (NCT06325722) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-08-28 |
| Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose (NCT06223555) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-08-23 |
| Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis (NCT05953545) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-05-22 |
| Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate (NCT06044935) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-01-08 |
| Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD) (NCT05996536) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2024-01-03 |
| Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (NCT05832229) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-12-07 |
| STOP-T1D Low-Dose (ATG) (NCT04291703) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-11-01 |
| Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes (NCT03929601) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-10-30 |
| Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) (NCT05743244) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-10-19 |
| The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure (NCT05545306) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-06-06 |
| Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach (NCT04685200) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-03-31 |
| Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease (NCT05669677) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-03-15 |
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance (NCT05470504) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-01-23 |
| A Natural History Study of Metabolic Sizing in Health and Disease (NCT05398783) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-10-25 |
| Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy (NCT05419037) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-09-07 |
| Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment (NCT05213598) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-09-07 |
| The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change (NCT04896060) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-09-01 |
| Vitamin E Dosing Study (NCT04801849) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-08-05 |
| Early Tracking of Childhood Health Determinants (ETCHED) Study (NCT03481829) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-04-14 |
| Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake (NCT04799301) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-02-23 |
| TReatment for ImmUne Mediated PathopHysiology (NCT04862221) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-02-09 |
| Evaluation of Patients With Gastrointestinal Disease (NCT05041374) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-01-04 |
| Natural History Study of Parathyroid Disorders (NCT04969926) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-11-30 |
| The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer (NCT04927416) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-10-25 |
| Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D (NCT04729296) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-07-01 |
| HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis (NCT04571619) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-01-03 |
| A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 (NCT04279613) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2020-11-23 |
| Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes (NCT03396484) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2020-09-01 |
| Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber) (NCT04209075) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2020-03-10 |
| The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer (NCT03841617) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-07-29 |
| Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) (NCT03884075) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-07-24 |
| Effects of Low Fat Versus Low Carbohydrate Diets on Energy Metabolism (NCT03878108) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-04-15 |
| Study of Endocrine-Related Conditions and Physiology (NCT03867448) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-03-27 |
| Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B (NCT03575208) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-02-13 |
| People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents (NCT03520660) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-10-19 |
| Losartan for the Treatment of Pediatric NAFLD (NCT03467217) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-10-02 |
| Brain Dopamine Function in Human Obesity (NCT03648892) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-09-21 |
| Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (NCT03428945) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-08-15 |
| Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon (NCT03600714) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-08-01 |
| Effect of Ultra Processed Versus Unprocessed Diets on Energy Intake (NCT03407053) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-03-01 |
| Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks (NCT03374215) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-12-14 |
| Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity (NCT03189121) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-11-20 |
| Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection (NCT03248622) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-06-03 |
| Empaglifozin in Early Diabetic Kidney Disease (NCT03173963) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-05-27 |
| Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes (NCT02960659) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-05-09 |
| Food Intake Response to Short-Term Modifications of Metabolism in Humans (NCT02939404) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-04-27 |
| The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists (NCT03049462) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-03-13 |
| Longitudinal Assessment of Transient Elastography in Cystic Fibrosis (NCT03001388) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-03-08 |
| MRI to Characterize and Predict CF Liver Disease in PUSH Cohort (NCT02979340) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-01-27 |
| Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study) (NCT05621304) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-01-03 |
| Gut Microbiome and p-Inulin in CKD - TarGut CKD Study (NCT03348592) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-10-01 |
| Evaluation of Adults With Endocrine and Metabolic-Related Conditions (NCT02830308) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-07-09 |
| A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases (NCT02639260) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-07-07 |
| Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism (NCT02692885) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-03-22 |
| Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20) (NCT02580877) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2016-01-01 |
| Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension (NCT02639286) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-12-23 |
| Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease (NCT02520609) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-10-28 |
| Quantifying the Persistence of Metabolic Adaptation and Weight Regain Following Extreme Weight Loss (NCT02544009) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-09-05 |
| Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir (NCT02511431) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-07-29 |
| Natural History of Noncirrhotic Portal Hypertension (NCT02417740) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-07-27 |
| Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 (NCT02468648) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-06-09 |
| Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis (NCT02400216) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-05-29 |
| Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations (NCT02457897) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-04-17 |
| Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) (NCT02363309) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-03-27 |
| Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment (NCT02364336) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-02-14 |
| Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRI (NCT02346474) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-01-24 |
| ATG-GCSF in New Onset Type 1 Diabetes (NCT02215200) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-12-01 |
| Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy (NCT02311348) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-11-20 |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy (NCT02262806) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-14 |
| Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women (NCT00862433) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-10 |
| Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy (NCT02262832) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-09 |
| Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers (NCT02404870) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-09-16 |
| Metabolic and Neural Adaptations to Weight Loss, Plateau, and Regain (NCT02199483) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-07-21 |
| Seroprevalence of Hepatitis E in People With an Organ Transplant (NCT02190253) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-07-12 |
| Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C (NCT02118012) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-03-20 |
| TODAY2 Phase 2 Follow-up (NCT02310724) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-03-01 |
| Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome (NCT02019706) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-02-12 |
| Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate (NCT01950520) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-02-07 |
| Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans (NCT02037295) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-01-14 |
| Study of the Effect of a Very-Low-Carbohydrate Diet on Energy Expenditure (NCT01967563) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-12-03 |
| Mechanisms of Diabetic Kidney Disease in American Indians (NCT01878045) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-11-07 |
| Evaluation of Sickle Cell Liver Disease (NCT01950429) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-10-16 |